Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Therapeutic Potential of Electrophilic Nitro-Oleic Acid for The Treatment of Triple-Negative Breast Cancer

Woodcock, Chen-Shan (2017) Therapeutic Potential of Electrophilic Nitro-Oleic Acid for The Treatment of Triple-Negative Breast Cancer. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

Download (2MB) | Preview


Triple negative breast cancer (TNBC) comprises ~20% of all breast cancers and is the most aggressive breast cancer subtype. Devoid of expression of the estrogen and progesterone receptors, along with the receptor tyrosine kinase ERB2 (HER2) that defines most mammary cancers, there are no targeted therapies for patients with TNBC. This, combined with a high metastatic rate and a lower 5-year survival rate than for other breast cancer phenotypes, means there is significant unmet need for new therapeutic strategies.

Herein, the anti-neoplastic effects of the electrophilic fatty acid nitroalkene derivative, 10-nitro-octadec-9-enoic acid (nitro-oleic acid, NO2-OA), were investigated in multiple preclinical models of TNBC. NO2-OA reduced TNBC cell growth and viability in vitro, attenuated TNFα-induced TNBC cell migration and invasion and inhibited the tumor growth of MDA-MB-231 TNBC cell xenografts in the mammary fat pads of female nude mice. The upregulation of these aggressive tumor cell growth, migration and invasion phenotypes is mediated in part by the constitutive activation of proinflammatory nuclear factor kappa B (NF-κB) signaling in TNBC. NO2-OA inhibited TNFα-induced NF-κB transcriptional activity in human TNBC cells and suppressed downstream NF-κB target gene expression, including the metastasis-related proteins intercellular adhesion molecule-1 (ICAM-1) and urokinase-type plasminogen activator (uPA).

The mechanisms accounting for NF-κB signaling inhibition by NO2-OA in TNBC cells were multifaceted, as NO2-OA a) inhibited the inhibitor of NF-κB subunit kinase β phosphorylation and downstream inhibitor of NF-κB degradation, b) alkylated the NF-κB RelA protein to prevent DNA binding and c) promoted RelA polyubiquitination and proteasomal degradation. Comparisons with nontumorigenic human breast epithelial MCF-10A cells revealed that NO2-OA more selectively inhibited TNBC function. This was attributed to greater extents of multi-drug resistance protein-1 (MRP1) expression and greater MRP1-mediated efflux of NO2-OA glutathione conjugates in MCF-10A cells. Blocking MRP1 transporting activity by inhibitor probenecid sensitized MCF-10A cells to NO2-OA similar to its effect on TNBC cells, indicating that MRP1-mediated efflux can profoundly attenuate the NO2-OA biological activity in MCF-10A cells. This dissertation study will be an important illustration of how NO2-OA inhibits TNBC tumor development and its elucidation may have significant impact for the improvement of pharmacological therapies.


Social Networking:
Share |


Item Type: University of Pittsburgh ETD
Status: Unpublished
CreatorsEmailPitt UsernameORCID
Woodcock, Chen-Shanjcsw17@pitt.edujcsw17
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee ChairOesterreich,
Thesis AdvisorFreeman,
Committee MemberDavidson,
Committee MemberHuang,
Committee MemberNeumann,
Committee MemberZarnegar,
Date: 19 December 2017
Date Type: Publication
Defense Date: 11 December 2017
Approval Date: 19 December 2017
Submission Date: 13 December 2017
Access Restriction: 5 year -- Restrict access to University of Pittsburgh for a period of 5 years.
Number of Pages: 144
Institution: University of Pittsburgh
Schools and Programs: School of Medicine > Pharmacology and Chemical Biology
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: Fatty acid nitroalkenes; Triple-negative breast cancer; NF-kappaB
Date Deposited: 19 Dec 2017 20:18
Last Modified: 19 Dec 2022 06:15


Monthly Views for the past 3 years

Plum Analytics

Actions (login required)

View Item View Item